上集講述了PD1/PDL1在醫治癌細胞免疫治療方面的重要性，接下來我們將會繼續深入探討問題。1393Please respect copyright.ＰＥＮＡＮＡHouP9DM5c5
1393Please respect copyright.ＰＥＮＡＮＡftlBxEmkKE
上集：https://www.penana.com/article/4711251393Please respect copyright.ＰＥＮＡＮＡc1ozrRhLvq
1393Please respect copyright.ＰＥＮＡＮＡ9FQPcRmKuR
1393Please respect copyright.ＰＥＮＡＮＡPko06dmzE2
1393Please respect copyright.ＰＥＮＡＮＡdFdkO2EZai
（圖1）雖然阻擋PD1/PDL1可以增強T cell辨認癌細胞的能力，但另一個重要的問題是，如何確保有足夠的T cell殺滅癌細胞呢?1393Please respect copyright.ＰＥＮＡＮＡstMFa9oRUi
1393Please respect copyright.ＰＥＮＡＮＡTL6BDDKVOu
就算成功糾正免疫系統細胞懂得把癌細胞辨認為外來之物，但免疫系統細胞數量不足的話，依然是不會達到重大效果的。1393Please respect copyright.ＰＥＮＡＮＡbZpXbDZ6Qm
1393Please respect copyright.ＰＥＮＡＮＡhb1WTH0R8b
換句話說，我們需要一道能夠提升針對癌細胞的T cell數量手段。1393Please respect copyright.ＰＥＮＡＮＡOGDBAbFKkL
1393Please respect copyright.ＰＥＮＡＮＡIwMrqZhAfD
1393Please respect copyright.ＰＥＮＡＮＡQYeJoK1EPi
1393Please respect copyright.ＰＥＮＡＮＡzx6w9wuh0e
（圖2）T cell的產生數量，接近可以說是由Antigen Presenting Cells(APC)來決定;1393Please respect copyright.ＰＥＮＡＮＡdvtWn6PtI4
APC可以睇成為一堆負責把癌細胞獨特Neoantigen帶來T cell面前的細胞。1393Please respect copyright.ＰＥＮＡＮＡchyjIruiz8
1393Please respect copyright.ＰＥＮＡＮＡ7ass0diDvB
忘記甚麼是Neoantigen的話，可重溫上一集。1393Please respect copyright.ＰＥＮＡＮＡMPXGtj9FkI
1393Please respect copyright.ＰＥＮＡＮＡDvWSZtjnuQ
當APC展示癌細胞的Neoantigen予T cell的receptor後，另一個必需的動作就是T cell表面的CD28與APC表面的B7合併。1393Please respect copyright.ＰＥＮＡＮＡXQgnzaeWpR
1393Please respect copyright.ＰＥＮＡＮＡsxGfprCtwX
只要兩者條件達成的話，負責對付對應癌細胞的T cell數量及效力便會大增。1393Please respect copyright.ＰＥＮＡＮＡkh6jGmDk9y
1393Please respect copyright.ＰＥＮＡＮＡKEiS04mNX5
1393Please respect copyright.ＰＥＮＡＮＡSs96gXJUUc
1393Please respect copyright.ＰＥＮＡＮＡhOZt3Yap6N
（圖3）然而，當T cell數量產生至一定程度的時候，T cell便會產生出CTLA4。CTLA4會搶奪CD28的位置，與B7合併。1393Please respect copyright.ＰＥＮＡＮＡ6kGggzpoFo
1393Please respect copyright.ＰＥＮＡＮＡQngAPnaHhb
而當CTLA4與B7合併後，T cell所產生的數量及威力就會大減。1393Please respect copyright.ＰＥＮＡＮＡMxBk3n96mj
1393Please respect copyright.ＰＥＮＡＮＡff5WOpaW5Y
這個CTLA4產生的機制是與生俱來的，目的就是為了避免產生過量的T cell，以免身體會產生不良反應。1393Please respect copyright.ＰＥＮＡＮＡLR6STFSfpz
1393Please respect copyright.ＰＥＮＡＮＡuZs36cHBDa
1393Please respect copyright.ＰＥＮＡＮＡ8hMFPD3fTk
（圖4）只不過的是，現時癌細胞大敵當前，燃眉之急就是要調動大量的T cell前往討伐癌細胞。1393Please respect copyright.ＰＥＮＡＮＡ8VGlg02FQc
1393Please respect copyright.ＰＥＮＡＮＡjSm8ue92XC
為此，我們重施應對PD1/PDL1故技，利用抗體阻擋CTLA4，確保CD28及B7持續合併，不斷產生效力高強的T cell。1393Please respect copyright.ＰＥＮＡＮＡRdJPU2WTAw
1393Please respect copyright.ＰＥＮＡＮＡlagpr2rqLp
1393Please respect copyright.ＰＥＮＡＮＡsxeb34oRXP
（圖5）簡略的總結來說，為了確保有足夠的T cell消滅癌細胞，我們不惜採用阻擋CTLA4的抗體，號令身體持續產生效力高強的T cell。1393Please respect copyright.ＰＥＮＡＮＡ5YCFNAiNM4
而另一邊廂，我們亦同時利用阻擋PD1/PDL1的抗體，確保T cell能夠順利把癌細胞辨認成為外來物，將其制裁。1393Please respect copyright.ＰＥＮＡＮＡstkRoobrEj
1393Please respect copyright.ＰＥＮＡＮＡzCEWqUxMtN
這CTLA4抗體及PD1/PDL1抗體的雙管齊下療法，將能大大提升免疫治療的效率。1393Please respect copyright.ＰＥＮＡＮＡvTgUoxAHij
1393Please respect copyright.ＰＥＮＡＮＡomWqPkGf6O
但是，並不是所有病人也能依靠這方法而得益，原因是T cell沒法能夠順利抵達癌細胞的位置以及滲入癌細胞的內部作有效的消滅。1393Please respect copyright.ＰＥＮＡＮＡ9yAzuxcS4L
1393Please respect copyright.ＰＥＮＡＮＡFlJKoe1w2j
這一方面，我們將會在下一篇免疫治療的最終章再作探討。1393Please respect copyright.ＰＥＮＡＮＡUioNRSlgUU
1393Please respect copyright.ＰＥＮＡＮＡP4oGwILbVL
1393Please respect copyright.ＰＥＮＡＮＡrtfR5iZHn6
如果想我快啲出文的話，請入去Penana網站科普專欄–薯不揀單俾一個like以及Bookmark，這對我非常之重要。1393Please respect copyright.ＰＥＮＡＮＡlajqMhGzC9
1393Please respect copyright.ＰＥＮＡＮＡO85uInrFPd
Link: https://www.penana.com/story/66244/%E7%A7%91%E6%99%AE%E5%B0%88%E6%AC%84-%E8%96%AF%E4%B8%8D%E6%8F%80%E5%96%AE/toc1393Please respect copyright.ＰＥＮＡＮＡZR8Dy0G7Do
1393Please respect copyright.ＰＥＮＡＮＡBIKOcOYnrq
同時亦可以在Penana網站裡按「買一嚿/半嚿薯仔」，以課金的方式推動我繼續搜羅資料寫文，多謝。1393Please respect copyright.ＰＥＮＡＮＡkVunOYRfM9
1393Please respect copyright.ＰＥＮＡＮＡwYJIwnFQqz
Link:1393Please respect copyright.ＰＥＮＡＮＡDSY3BtMWRX
https://www.penana.com/user/27349/%E8%96%AF%E4%BB%94%E8%81%9E%E8%8C%B1%E8%8E%89/portfolio1393Please respect copyright.ＰＥＮＡＮＡ1zsNJWzlGX
1393Please respect copyright.ＰＥＮＡＮＡXW9lW6hC72
1393Please respect copyright.ＰＥＮＡＮＡxIWEgOL8By
有興趣接收科普資訊的話，歡迎follow IG: potatopigtongue。1393Please respect copyright.ＰＥＮＡＮＡt9Co4OJuvP
Penana
search
登入arrow_drop_down
註冊arrow_drop_down
